亚洲人成电影在线小说网色,国产av一区二区精品凹凸,免费特级黄毛片在线成人观看,亚洲最大国产成人综合网站,久久国产情侣露脸精品,国产成人亚洲精品,国产精品久久久久久一区二区三区,成人a级视频在线播放,国产精品无码无卡无需播放器,久久久久久久久久亚洲精品

2023/01/11 PHARMCUBE Colum

PHARMCUBE Colum | Dr. Xiaodun Mou: Base Editing Therapy is Expected to Open a New Chapter of Disease Treatment

As one of the most important technologies in the field of life science in the 21st century, gene editing technology is gradually showing its application potential and vigorous development. According to the data, the global genome editing market is expected to reach $4.3 billion in 2022 and $12.8 billion in 2027. The global genome editing market is expected to grow at a compound annual growth rate of 24.7% in 2022-2027.

Details

2022/10/12 Sequoiacap

[Sequoia Talk] Jiang Han x Xiaodun Mou: Turning Scissor into Pen, Base Editing Technology Leads Cell and Gene Therapy into Minimally Invasive Era

Following the successful holding of the first science and technology event, Sequoia Talk series Forum medical event recently came to a successful conclusion. In the gene editing session, Mr. Jiang Han, Director & General Manager of Sequoia China, and Dr. Xiaodun Mou, CEO of CorrectSequence Therapeutics (Correctseq), presented a wonderful sharing of cutting-edge gene editing technologies and innovative treatment solutions with the theme of "Turning Knife into Pen, Base Editing Leads Cell and Gene Therapy into Minimally Invasive Era".

Details

2022/08/01 SciPhi

Develop Innovative Base Editing System and Nearly 10 Pipelines, 1st Pipeline be IND Ready By 2023

Recently, CorrectSequence Therapeutics (Correctseq), a biotechnology company aims to use their own innovative gene editing system to help people living with serious diseases, announced that transformer Base Editor (tBE) developed independently is authorized by USPTO (United States Patent and Trademark Office) formally and became the Chinese first base editing tool authorized by overseas patents.

Details

2022/07/14 PhIRDA

Chinese First Base Editing Tool Authorized by Overseas Patent

tBE(transformer Base Editor), developed by the scientific co-founders of CorrectSequence Therapeutics (Correctseq), is authorized by USPTO (United States Patent and Trademark Office) formally. It’s th

Details

2021/03/27 SDDA

Turning a Scissor into a Pen, CRISPR 2.0 Era is Coming

In face of tens of thousands of unsolved difficult diseases, gene editing technology known as "God's scalpel" is expected. Like turning knives into pens, several young Chinese scientists in Zhangjiang of Shanghai are committed to developing novel gene editors without making a double-stranded break in the DNA, directly modifying the wrong genetic information. In the trend of entrepreneurship, they want to develop the advanced gene editing technology into a precision genetic therapy of variety of genetic and tumor diseases as soon as possible.

Details